Evidence map›Paper›PMID 29633184›Full record

Observational studyClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2018

Evaluation of waiting times for breast cancer diagnosis and surgical treatment.

J M Baena-Cañada, L Rodríguez-Pérez, S Gámez-Casado, A Quílez-Cutillas, C Cortés-Carmona, P Rosado-Varela, S Estalella-Mendoza, P Ramírez-Daffós, J Jaén-Olasolo, E Benítez-Rodríguez

Abstract readObservational Study
PubMed Publisher
In one paragraph

Observational study in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

J M Baena-CañadaDepartment of Medical Oncology, University Hospital Puerta del Mar, Avenida de Ana de Viya 21, 11009, Cádiz, Spain. josem.baena.sspa@juntadeandalucia.es.ORCID http://orcid.org/0000-0002-8403-9804
L Rodríguez-PérezDepartment of Medical Oncology, University Hospital Puerta del Mar, Avenida de Ana de Viya 21, 11009, Cádiz, Spain.
S Gámez-CasadoDepartment of Medical Oncology, University Hospital Puerta del Mar, Avenida de Ana de Viya 21, 11009, Cádiz, Spain.
A Quílez-CutillasDepartment of Medical Oncology, University Hospital Puerta del Mar, Avenida de Ana de Viya 21, 11009, Cádiz, Spain.
C Cortés-CarmonaDepartment of Medical Oncology, University Hospital Puerta del Mar, Avenida de Ana de Viya 21, 11009, Cádiz, Spain.
P Rosado-VarelaDepartment of Medical Oncology, University Hospital Puerto Real, Carretera Nacional IV, Km. 665, Puerto Real, 11510, Cádiz, Spain.
S Estalella-MendozaDepartment of Medical Oncology, University Hospital Puerta del Mar, Avenida de Ana de Viya 21, 11009, Cádiz, Spain.
P Ramírez-DaffósDepartment of Medical Oncology, University Hospital Puerta del Mar, Avenida de Ana de Viya 21, 11009, Cádiz, Spain.
J Jaén-OlasoloDepartment of Radiation Oncology, University Hospital Puerta del Mar, Avda. Ana de Viya 21, 11009, Cádiz, Spain.
E Benítez-RodríguezHealth Department, Provincial Cancer Registry, Calle María Auxiliadora, 2, 11009, Cádiz, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo analyse any delays in breast cancer diagnosis and surgical treatment, influence of clinical and biological factors and influence of delays on survival. METHODS/PATIENTS: A descriptive, observational, and retrospective study was conducted between 2006 and 2016 on stages I-III breast cancer patients. This is a retrospective review of health records to collect data on delays, patients' clinical data, biological features of the tumour and information on treatment. Mortality data from the National Death Index.

resultsIn 493 evaluable patients, the median of days from the first symptom to mammography, biopsy, and surgery was 41, 57, and 92, respectively. The median of days from screening mammography to biopsy and surgery was 10 and 51, respectively. From biopsy to surgery, the median was 34 days in every case. Over the last 5 years, an increase in biopsy-surgery delay has been observed (p = 0.0001). Tumour stages I and II vs. stage III (RR 1.74. 95% CI 1.08-2.80, p = 0.027), diagnosis in screening (RR 0.66. 95% CI 0.45-0.96, p = 0.030), and use of magnetic resonance imaging (RR 2.08. 95 CI 1.21-3.56, p = 0.008) condition a greater biopsy-surgery delay. No influence of delays on survival has been identified.

conclusionsDelays in diagnosis and surgery in the case of women diagnosed on the basis of symptoms may be improved. There is a temporary tendency to a greater delay in surgery. Some clinical and biological factors must be taken into account to optimise delays. Survival results are not adversely affected by delays.

Indexed as

AdultAgedAged, 80 and overBreast NeoplasmsDelayed DiagnosisFemaleHumansMiddle AgedRetrospective StudiesYoung AdultBreast cancerDelayDiagnosisSurgery

Identifiers

PMID29633184

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.